{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:56:26Z","timestamp":1792857386184,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jaip.2023.05.015","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T01:12:30Z","timestamp":1684890750000},"page":"1998-2006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Extrinsic and Intrinsic Modulators of Anaphylaxis"],"prefix":"10.1016","volume":"11","author":[{"given":"Melody C.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margitta","family":"Worm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.05.015_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2023.05.015_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","article-title":"Anaphylaxis--a practice parameter update 2015","volume":"115","author":"Lieberman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2023.05.015_bib4","first-page":"44","article-title":"Causes and risk factors for anaphylaxis","volume":"11","author":"Worm","year":"2013","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaip.2023.05.015_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","article-title":"Diagnosis and management of anaphylaxis in precision medicine","volume":"140","author":"Castells","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib6","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1177\/13591053211014583","article-title":"Depression, psychosocial correlates, and psychosocial resources in individuals with mast cell activation syndrome","volume":"27","author":"Nicoloro SantaBarbara","year":"2022","journal-title":"J\u00a0Health Psychol"},{"key":"10.1016\/j.jaip.2023.05.015_bib7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/all.13380","article-title":"Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from The European Anaphylaxis Registry","volume":"73","author":"Worm","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00105-012-2451-7","article-title":"Exercise-induced anaphylaxis [in German]","volume":"64","author":"Wylon","year":"2013","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaip.2023.05.015_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5414\/ALX01320E","article-title":"Risk factors in Hymenoptera venom allergy","volume":"1","author":"Rueff","year":"2017","journal-title":"Allergol Select"},{"key":"10.1016\/j.jaip.2023.05.015_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa070030","article-title":"Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis","volume":"358","author":"Vadas","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.015_bib11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations","volume":"130","author":"Bodemer","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2023.05.015_bib12","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2023.05.015_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000237541","article-title":"c-kit mutation in a population of patients with mastocytosis","volume":"113","author":"Nagata","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib14","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2023.05.015_bib15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1398-9995.1990.tb00945.x","article-title":"Mastocytosis and atopy: a study of 33 patients with urticaria pigmentosa","volume":"45","author":"M\u00fcller","year":"1990","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaci.2012.12.1578","article-title":"Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis","volume":"132","author":"van Anrooij","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib18","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonz\u00e1lez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib106","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2023.05.015_bib107","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.aller.2014.05.002","article-title":"Clinical characteristics and risk profile of patients with elevated baseline serum tryptase","volume":"42","author":"Fellinger","year":"2014","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2023.05.015_bib108","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1515\/CCLM.2010.124","article-title":"Factors influencing serum total tryptase concentrations in a general adult population","volume":"48","author":"Gonzalez-Quintela","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jaip.2023.05.015_bib111","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib109","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.05.015_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaci.2008.10.052","article-title":"Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose","volume":"123","author":"Commins","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.iac.2015.01.009","article-title":"Anaphylaxis to the carbohydrate side chain alpha-gal","volume":"35","author":"Platts-Mills","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2023.05.015_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaip.2019.09.017","article-title":"Diagnosis and management of patients with the alpha-gal syndrome","volume":"8","author":"Platts-Mills","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.015_bib23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaci.2014.12.1947","article-title":"The alpha-gal story: lessons learned from connecting the dots","volume":"135","author":"Steinke","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib24","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose","volume":"358","author":"Chung","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.015_bib25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/all.13366","article-title":"Identification of alpha-gal sensitivity in patients with a diagnosis of idiopathic anaphylaxis","volume":"73","author":"Carter","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11882-015-0525-1","article-title":"Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?","volume":"15","author":"Matito","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2023.05.015_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A\u00a0distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis","volume":"141","author":"Carter","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","article-title":"Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms","volume":"157","author":"Alvarez-Twose","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib29","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1398-9995.2008.01719.x","article-title":"Paediatric anaphylaxis: a 5 year retrospective review","volume":"63","author":"de Silva","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib30","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.jaip.2021.01.010","article-title":"Trends in US emergency department visits for anaphylaxis among infants and toddlers: 2006-2015","volume":"9","author":"Robinson","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.015_bib31","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.pedhc.2012.12.011","article-title":"Anaphylaxis in the pediatric patient: optimizing management and prevention","volume":"27","author":"Wagner","year":"2013","journal-title":"J\u00a0Pediatr Health Care"},{"key":"10.1016\/j.jaip.2023.05.015_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0009922812474683","article-title":"Update in pediatric anaphylaxis: a systematic review","volume":"52","author":"Chipps","year":"2013","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jaip.2023.05.015_bib33","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1365-2222.2000.00864.x","article-title":"Lessons for management of anaphylaxis from a study of fatal reactions","volume":"30","author":"Pumphrey","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib34","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jaci.2006.12.622","article-title":"Further fatalities caused by anaphylactic reactions to food, 2001-2006","volume":"119","author":"Bock","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib35","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM199208063270603","article-title":"Fatal and near-fatal anaphylactic reactions to food in children and adolescents","volume":"327","author":"Sampson","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.015_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/JAA.S42694","article-title":"Infant anaphylaxis: the importance of early recognition","volume":"6","author":"Dosanjh","year":"2013","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/PEC.0b013e3181ce2e1c","article-title":"Anaphylaxis management in the pediatric emergency department: opportunities for improvement","volume":"26","author":"Russell","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.jaip.2023.05.015_bib38","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.pcl.2019.06.005","article-title":"Anaphylaxis in children and adolescents","volume":"66","author":"Poowuttikul","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jaip.2023.05.015_bib39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13223-018-0234-0","article-title":"Critical view of anaphylaxis epidemiology: open questions and new perspectives","volume":"14","author":"Tanno","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.aller.2010.12.012","article-title":"Anaphylaxis in children: a nine years retrospective study (2001-2009)","volume":"40","author":"Silva","year":"2012","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2023.05.015_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13049-017-0402-0","article-title":"Anaphylaxis in an emergency care setting: a one year prospective study in children and adults","volume":"25","author":"Ruiz Oropeza","year":"2017","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"10.1016\/j.jaip.2023.05.015_bib42","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.jaip.2019.04.025","article-title":"Epidemiology of anaphylaxis in critically ill children in the United States and Canada","volume":"7","author":"Ramsey","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.015_bib43","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3390\/ijms22052684","article-title":"Mediator-related symptoms and anaphylaxis in children with mastocytosis","volume":"22","author":"Brockow","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2023.05.015_bib44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1398-9995.2012.02812.x","article-title":"Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis","volume":"67","author":"Alvarez-Twose","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib45","first-page":"81","article-title":"Unexpected reactions to vaccines in children with mastocytosis: an observational study","volume":"7","author":"H Abuhay","year":"2020","journal-title":"J\u00a0Pediatr Res"},{"key":"10.1016\/j.jaip.2023.05.015_bib46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/pai.12647","article-title":"Evaluation of vaccination safety in children with mastocytosis","volume":"28","author":"Parente","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib47","doi-asserted-by":"crossref","first-page":"e1545","DOI":"10.1542\/peds.2012-2585","article-title":"Galactose-alpha-1,3-galactose and delayed anaphylaxis, angioedema, and urticaria in children","volume":"131","author":"Kennedy","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2023.05.015_bib48","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jaip.2018.06.005","article-title":"Anaphylaxis after vaccination in a pediatric patient: further implicating alpha-gal allergy","volume":"7","author":"Stone","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.015_bib49","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.jaci.2016.10.037","article-title":"Anaphylaxis after zoster vaccine: implicating alpha-gal allergy as a possible mechanism","volume":"139","author":"Stone","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/0470861193.ch10","article-title":"Fatal anaphylaxis in the UK, 1992-2001","volume":"257","author":"Pumphrey","year":"2004","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.jaip.2023.05.015_bib51","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1346-8138.2012.01520.x","article-title":"Promising option in the prevention of idiopathic anaphylaxis: omalizumab","volume":"39","author":"Demirt\u00fcrk","year":"2012","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaip.2023.05.015_bib52","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S1081-1206(10)60296-7","article-title":"Idiopathic anaphylaxis successfully treated with omalizumab","volume":"101","author":"Jones","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2010.05.043","article-title":"Successful treatment of idiopathic anaphylaxis in an adolescent","volume":"126","author":"Pitt","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1081-1206(10)60091-9","article-title":"Omalizumab in idiopathic anaphylaxis","volume":"102","author":"Warrier","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib55","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/all.13237","article-title":"Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: efficacy and safety observations","volume":"73","author":"Broesby-Olsen","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib56","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaip.2018.07.041","article-title":"Twelve-year follow-up of omalizumab therapy for anaphylaxis in 2 patients with systemic mastocytosis","volume":"7","author":"Constantine","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.015_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2019.09.026","article-title":"Clinical response to omalizumab in patients with hereditary \u03b1-tryptasemia","volume":"124","author":"Mendoza Alvarez","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib58","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/biof.1888","article-title":"The role of PAF in immunopathology: from immediate hypersensitivity reactions to fungal defense","volume":"48","author":"S\u00e1nchez Crespo","year":"2022","journal-title":"BioFactors"},{"key":"10.1016\/j.jaip.2023.05.015_bib59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4049\/jimmunol.1901393","article-title":"Thermal burn injury generates bioactive microvesicles: evidence for a novel transport mechanism for the lipid mediator platelet-activating factor (PAF) that involves subcellular particles and the PAF receptor","volume":"205","author":"Liu","year":"2020","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib60","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/biof.1883","article-title":"Platelet activating factor (PAF): a mediator of inflammation","volume":"48","author":"Upton","year":"2022","journal-title":"BioFactors"},{"key":"10.1016\/j.jaip.2023.05.015_bib61","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1164\/ajrccm\/147.5.1223","article-title":"The effects of combined histamine and platelet-activating factor antagonism on systemic anaphylaxis induced by immunoglobulin E in the rabbit","volume":"147","author":"Lohman","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2023.05.015_bib62","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lfs.2014.09.010","article-title":"Mouse anaphylactic shock is caused by reduced cardiac output, but not by systemic vasodilatation or pulmonary vasoconstriction, via PAF and histamine","volume":"116","author":"Wang","year":"2014","journal-title":"Life Sci"},{"key":"10.1016\/j.jaip.2023.05.015_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2016.01.034","article-title":"The responses of pulmonary and systemic circulation and airway to anaphylactic mediators in anesthetized BALB\/c mice","volume":"147","author":"Wang","year":"2016","journal-title":"Life Sci"},{"key":"10.1016\/j.jaip.2023.05.015_bib64","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/cea.13540","article-title":"Treatment with a platelet-activating factor receptor antagonist improves hemodynamics and reduces epinephrine requirements, in a lethal rodent model of anaphylactic shock","volume":"50","author":"Tacquard","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib65","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000141516","article-title":"PAF, rather than histamine, participates in mouse anaphylactic hypotension","volume":"82","author":"Shibamoto","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.jaip.2023.05.015_bib66","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2249.1995.tb03711.x","article-title":"Occurrence of disseminated intravascular coagulation (DIC) in active systemic anaphylaxis: role of platelet-activating factor","volume":"100","author":"Choi","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib67","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1203\/00006450-199712000-00010","article-title":"The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis","volume":"42","author":"Caplan","year":"1997","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaip.2023.05.015_bib68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(99)00920-6","article-title":"Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models","volume":"390","author":"Fukuda","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaip.2023.05.015_bib69","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jaci.2009.03.012","article-title":"Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions","volume":"124","author":"Arias","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib70","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1203\/PDR.0b013e3181eb2efe","article-title":"Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis","volume":"68","author":"Lu","year":"2010","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaip.2023.05.015_bib71","first-page":"175","article-title":"Changes of prostaglandin D2, carboxypeptidase A3 and platelet activating factor in guinea pig in anaphylactic shock [in Chinese]","volume":"28","author":"Yang","year":"2012","journal-title":"Fa Yi Xue Za Zhi"},{"key":"10.1016\/j.jaip.2023.05.015_bib72","doi-asserted-by":"crossref","first-page":"52762","DOI":"10.1039\/C7RA09268G","article-title":"Epinephrine inhibits vascular hyperpermeability during platelet-activating factor- or ovalbumin-induced anaphylaxis","volume":"7","author":"Ma","year":"2017","journal-title":"RSC Adv"},{"key":"10.1016\/j.jaip.2023.05.015_bib73","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biochi.2010.02.011","article-title":"The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses","volume":"92","author":"Yost","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.jaip.2023.05.015_bib74","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1084\/jem.187.11.1779","article-title":"Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor","volume":"187","author":"Ishii","year":"1998","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2023.05.015_bib75","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1710-1492-10-20","article-title":"Relationship between platelet activating factor acetylhydrolase activity and apolipoprotein B levels in patients with peanut allergy","volume":"10","author":"Perelman","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib76","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaci.2012.02.027","article-title":"Effect of epinephrine on platelet-activating factor\u2013stimulated human vascular smooth muscle cells","volume":"129","author":"Vadas","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib77","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.015_bib78","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.iac.2021.09.009","article-title":"Patient communications","volume":"42","author":"Collie","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2023.05.015_bib79","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/oxfordjournals.jbchem.a003145","article-title":"Platelet-activating factor acetylhydrolase (PAF-AH)","volume":"131","author":"Arai","year":"2002","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.jaip.2023.05.015_bib80","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0163-7827(02)00049-8","article-title":"Plasma platelet activating factor-acetylhydrolase (PAF-AH)","volume":"42","author":"Karasawa","year":"2003","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jaip.2023.05.015_bib81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10557-008-6133-8","article-title":"Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2)","volume":"23","author":"Stafforini","year":"2009","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jaip.2023.05.015_bib82","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2005.07.029","article-title":"Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration","volume":"186","author":"Zhang","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaip.2023.05.015_bib83","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jaci.2015.04.019","article-title":"Platelets in the immune response: revisiting platelet-activating factor in anaphylaxis","volume":"135","author":"Gill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256168","article-title":"Clinical significance of plasma PAF acetylhydrolase activity measurements as a biomarker of anaphylaxis: cross-sectional study","volume":"16","author":"Piwowarek","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2023.05.015_bib85","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaci.2013.10.033","article-title":"Basal platelet-activating factor acetylhydrolase: prognostic marker of severe Hymenoptera venom anaphylaxis","volume":"133","author":"Pravettoni","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib86","article-title":"Platelet-activating factor-acetylhydrolase gene (PLA2G7) expression in children with a history of food anaphylaxis","volume":"6","author":"Esakova","year":"2015","journal-title":"J\u00a0Allergy Ther"},{"key":"10.1016\/j.jaip.2023.05.015_bib87","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/1744666X.2019.1562904","article-title":"Exercise-induced anaphylaxis: causes, consequences, and management recommendations","volume":"15","author":"Christensen","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib88","first-page":"G84","article-title":"Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved","volume":"272","author":"Gue","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jaip.2023.05.015_bib89","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib90","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.anai.2017.07.014","article-title":"Risk factors for severe anaphylaxis in the United States","volume":"119","author":"Motosue","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib91","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib92","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/iid3.120","article-title":"Cofactors in allergic reactions to food: physical exercise and alcohol are the most important","volume":"4","author":"Versluis","year":"2016","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaip.2023.05.015_bib93","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaip.2017.12.023","article-title":"Exercise lowers threshold and increases severity, but wheat-dependent, exercise-induced anaphylaxis can be elicited at rest","volume":"6","author":"Christensen","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.015_bib94","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jaci.2019.06.038","article-title":"Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: a randomized controlled study","volume":"144","author":"Dua","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib95","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/2045-7022-3-38","article-title":"Elicitors and co-factors in food-induced anaphylaxis in adults","volume":"3","author":"Hompes","year":"2013","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib96","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaip.2018.06.018","article-title":"Wheat-dependent cofactor-augmented anaphylaxis: a prospective study of exercise, aspirin, and alcohol efficacy as cofactors","volume":"7","author":"Christensen","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.015_bib97","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaip.2018.10.042","article-title":"Relationship between anaphylaxis and use of beta-blockers and angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis of observational studies","volume":"7","author":"Tejedor-Alonso","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.015_bib98","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaci.2014.10.021","article-title":"Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012","volume":"135","author":"Turner","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib99","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1398-9995.2012.02829.x","article-title":"Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10","volume":"67","author":"Tanno","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib100","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1111\/all.14352","article-title":"Fatal anaphylaxis in Italy: analysis of cause-of-death national data, 2004-2016","volume":"75","author":"Bilo","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib101","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jaci.2017.02.014","article-title":"Fatal anaphylaxis in France: analysis of national anaphylaxis data, 1979-2011","volume":"140","author":"Pouessel","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib102","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1710-1492-10-38","article-title":"Anaphylaxis-related deaths in Ontario: a retrospective review of cases from 1986 to 2011","volume":"10","author":"Xu","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib103","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/cea.12748","article-title":"Increases in anaphylaxis fatalities in Australia from 1997 to 2013","volume":"46","author":"Mullins","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.015_bib104","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2008.10.049","article-title":"Anaphylaxis fatalities and admissions in Australia","volume":"123","author":"Liew","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.015_bib105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000339749","article-title":"Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients","volume":"160","author":"Sala-Cunill","year":"2013","journal-title":"Int Arch Allergy Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823005512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823005512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T16:38:19Z","timestamp":1736872699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823005512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":109,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2213219823005512"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.05.015","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrinsic and Intrinsic Modulators of Anaphylaxis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}